Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 29,821 shares at $121.37 ($3.6M) on 2022-04-11, disclosed to the SEC on 2022-04-11.
Seasonal sale ($3.6M) by CVP, Critical Care — this insider has traded EW in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.37 | 9,821 | $1.2M | 32.8% |
| 2 | $121.37 | 9,821 | $1.2M | 32.8% |
| 3 | $122.12 | 3,600 | $440K | 12.1% |
| 4 | $123.00 | 6,579 | $809K | 22.3% |
| Total | $121.82 avg | 29,821 | $3.6M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |